Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06129604 · ClinicalTrials.gov registry record · Phase 2
Pilot Window of Opportunity Trial (POET)
A Phase 2 study of Endometrial Carcinoma (EC) and Colorectal Carcinoma (CRC), sponsored by University of Oklahoma.
- Active
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06129604 is a Phase 2 study of Endometrial Carcinoma (EC) and Colorectal Carcinoma (CRC) that is active but no longer recruiting, run by University of Oklahoma. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06129604, a Phase 2 study of Endometrial Carcinoma (EC) and Colorectal Carcinoma (CRC), is active but no longer recruiting, sponsored by University of Oklahoma.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed clinical trial with TPST-1495 can help people with two types of cancer, Endometrial Cancer (EC) and Colorectal Carcinoma (CRC), who need surgery. The investigator plans to evaluate how well TPST-1495 works against these cancers by checking blood samples and tumor tissues taken before and after the treatment to see if it is an effective treatment option to help the immune system fight against cancer.
Conditions Studied
Interventions
- DRUG TPST-1495
Study Locations (1)
Oklahoma
- OU Health Stephenson Cancer Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-04-03 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06129604
The ClinicalTrials.gov registry entry for NCT06129604 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Endometrial Carcinoma (EC) appearing as the primary indexed condition, and to 1 intervention - of which TPST-1495 is the first listed.
NCT06129604 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06129604 about?
NCT06129604 is a clinical study titled "Pilot Window of Opportunity Trial (POET)". The proposed clinical trial with TPST-1495 can help people with two types of cancer, Endometrial Cancer (EC) and Colorectal Carcinoma (CRC), who need surgery. The investigator plans to evaluate how well TPST-1495 works against these cancers by checking blood samples and tumor tissues taken before an...
What is the current status of trial NCT06129604?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2024-04-03. Estimated completion is 2026-06-30.
What conditions does trial NCT06129604 study?
This clinical trial studies the following conditions: Endometrial Carcinoma (EC), Colorectal Carcinoma (CRC).
What interventions are being tested in trial NCT06129604?
The interventions under investigation include: TPST-1495 (DRUG).
Who is sponsoring clinical trial NCT06129604?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06129604 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Carcinoma (EC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.